Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GDUFA IV: US FDA Seeks To Codify Domestic Manufacturing ANDA Prioritization Pilot
Feb 05 2026
•
By
Derrick Gingery
The FDA also wants to extend ANDA review goal dates when data integrity issues are discovered.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from United States